Similar Articles

The Role of Hyperhomocysteinemia in İschemic Stroke

Şeref DEMİRKAYA, Okay VURAL, Ahmet AYDIN, Zeki GÖKÇİL, M. Akif TOPÇUOĞLU, Aşkın IŞIMER

Issue: 1999, Volume 5 - Issue 2
0 376

The Effect of Methylprednisolone on Disease Progression in Relapsing Remitting Multiple Sclerosis: six year-follow up results.

D. İ. GÜNAL, M. GÜLERYÜZ, E. KARAGÖZ, N. BEKİROĞLU, S. AKTAN

Issue: 1999, Volume 5 - Issue 1
0 254

Multiple Sclerosis and Fatigue

Nur YÜCEYAR, Ayşe SAĞDUYU

Issue: 1999, Volume 5 - Issue 1
0 241

Atrial Septal Aneurysm As A Cause of İschemic Stroke: Case Report

M. M. Sümer, M. KAHRAMAN, I. ÖZDEMİR, M. MOĞULKOÇ

Issue: 1998, Volume 4 - Issue 3-4
0 245

Clinical Scales for Multiple Sclerosis

Kadriye ARMUTLU, Rana KARABUDAK

Issue: 1997, Volume 3 - Issue 3-4
0 346

Ege Stroke Data Bank: An Analysis of 2000 Patients With Stroke

Emre KUMRAL, Bekir ÖZKAYA, Egemen VARDARLI, Ayşe SAĞDUYU, Hadiye ŞİRİN, Murat PEHLİVAN

Issue: 1997, Volume 3 - Issue 1-2
0 258

Clinical and Lesion Related Features in Acute Cerebral Infarcts which have Hemorrhagic Transformation

Şerefnur ÖZTÜRK, Taşkın DUMAN, Tülay ÖZTAŞ, Şenay ÖZBAKIR

Issue: 1997, Volume 3 - Issue 1-2
0 313

HLA Tissue Antigens in Multiple Sclerosis

Yaşar ZORLU, Fadime GÜVEN, Serdar KESKEN, Füsun KARAASLAN, Halis GÜGÜL

Issue: 1996, Volume 2 - Issue 3-4
0 298

Serum Vitamin B12 and Folate Levels in Multiple Sclerosis

H. Özden ŞENER, Serpil DEMİRCİ, Nermin MUTLUER

Issue: 1996, Volume 2 - Issue 3-4
0 431

Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.

Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM

Issue: 1996, Volume 2 - Issue 1-2
0 250

Manic Attack in İschemic Stroke: Case Report

Hayriye KÜÇÜKOĞLU, Ayten CEYHAN, Lütfü HANOĞLU, Sevim BAYBAŞ

Issue: 1996, Volume 2 - Issue 1-2
0 317

THE ROLE OF CYTOKINES IN MULTIPLE SCLEROSIS

Ayşe ALTINTAŞ, Orhun KANTARCI, Aksel SİVA

Issue: 1995, Volume 1 - Issue 4
0 251

SEREBROVASKULER HASTALIKLAR VE EPİLEPSİ

Ali YAKIT, Aytekin AKYÜZ, Şefik DENER, Kamil TOPALKARA, Suat Topaktaş

Issue: 1995, Volume 1 - Issue 4
0 259

Multiple Sclerosis Cases with Atypical Signs

Türe TUNÇBAY, Dilek EVYAPAN, Neşe ÇELEBİSOY

Issue: 1995, Volume 1 - Issue 2
0 375

Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy

DOI: 10.4274/tnd.2021.63444

Issue: 2021, Volume 27 - Supplement 1
0 444

Is a Brain Stroke Caused by COVID-19 Seen Under Two Years of Age? A Case Report

Mohammad Vafaee Shahi, Sedigheh Yousefzadegan, Ramin Zare Mahmoudabadi, Fatemeh Ahmadi, Aina Riahi

DOI: 10.4274/tnd.2021.42492

Issue: 2021, Volume 27 - Supplement 1
0 414

COVID-19-associated Leukoencephalopathy Involving the Splenium of the Corpus Callosum

Özlem Kayım Yıldız, Bülent Yıldız, Mürşit Hasbek, Gülsüm Aslı Tatlı, Murtaza Öz

DOI: 10.4274/tnd.2021.38445

Issue: 2021, Volume 27 - Supplement 1
0 369

The lmmunopathogenesis of Multiple Sclerosis

Nihal Işık

Issue: 2009, Volume 15 - Supplement 3
0 374

Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis

Rana KARABUDAK

Issue: 2009, Volume 15 - Supplement 3
0 418

Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies

Muhteşem GEDİZOĞLU

Issue: 2009, Volume 15 - Supplement 3
0 317